Canntab Therapeutics Limited intends to appoint Larry Latowsky as a Director and Executive Chairman of the Board. Mr. Latowsky is in the process of obtaining Health Canada approval to his planned appointment as Director and Executive Chairman of the Company. Mr. Latowsky become its Executive Chairman of the Board and lead the commercialization strategy with great emphasis on distribution channels around the world.